Methylated CpG points identified within MAGE-1 promoter are involved in gene repression

International Journal of Cancer

Volumn 68, Issue 4, 1996, Pages 464-470

  Serrano, Alfonso ^a   García, Angel ^a   Abril, Eduarde ^a   Garrido, Federico ^a   Ruiz Cabello, Francisco ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MELANOMA ANTIGEN 1; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; TUMOR CELL LINE;

ANTIGENS, NEOPLASM; AZACITIDINE; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029837009     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961115)68:4<464::AID-IJC11>3.0.CO;2-5     Document Type: Article

References (25)

1. AMAR-COSTESEC, A., GODELAINE, D., STOCKERT, E., VAN DER BRUG- GEN, P., BEAUFAY, H. and CHEN, Y.T., The tumor protein MAGE-1 is located in the cytosol of human melanoma cells. Biochem. Biophys. Res. Comm., 204, 710-715 (1994).
2. BECKER, P.B., RUPPERT, S. and SCHÜTZ, G., Genomic footprinting reveals cell-type-specific DNA binding of ubiquitous factors. Cell, 51, 435-443 (1987).
3. BRASSEUR, F., MARCHAND, M., VANWIJCK, R., HERIN, M., LETHE, B., CHOMEZ, P. and BOON, T., Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int. J. Cancer, 52, 839-841 (1992).
4. CEDAR, H., DNA methylation and gene activity. Cell, 53, 3-4 (1995).
5. DL PLAEN, E. and 14 OTHERS, Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics, 40, 360-369 (1994).
6. DE SMET, C., COURTOIS, S.J., FARAONI, I., LUROUIN, C., SZIKORA, J.P., DE BACKER, O. and BOON, T., Involvement of two Ets binding sites in the transcriptional activation of the Mage-1 gene. Immunogenetics, 42, 282-290 (1995).
7. DE SMET, C., LURQUIN, C., VAN DER BRUGGEN, P., DE PLAEN, E., BRASSEUR, F. and BOON, T., Sequence and expression pattern of the human MAGE2 gene. Immunogenetics, 39, 121-129 (1994).
8. DIGNAM, J.D., LEBOVITZ, R.M. and ROEDER, R.G., Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl. Acids Res., 11, 1475-1489 (1983).
9. GARTLER, S.M. and GOLDMAN, M.A., Reactivation of inactive X-linked genes. Devel. Genet., 15, 504-514 (1994).
10. GASTON, K. and FRIED, M., CpG methylation and the binding of YY1 and ETS proteins to the Surf-1/Surf-2 bidirectional promoter. Gene, 157, 257-259 (1995a).
11. GASTON, K. and FRIED, M., CpG methylation has differential effects on the binding of YY1 and ETS proteins to the bi-directional promoter of the Surf-1 and Surf-2 genes. Nucl. Acids. Res., 23, 901-909 (1995b).
12. JONES, P.A. and BUCKLEY, J.D., The role of DNA methylation in cancer. Advanc. Cancer Res., 54, 1-23 (1990).
13. LAIRD, P.W. and JAENISCH, R., DNA methylation and cancer. Hum. mol. Genet., 3, 1487-1495 (1994).
14. NORDEEN, S.K., Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques, 6, 454-457 (1988).
15. PARDOLL, D.M., Cancer vaccines. Immunol. Today, 14, 310-316 (1993).
16. RODRIGUEZ, F., PERAN, F., GARRIDO, F. and Ruiz CABELLO, F., Upmodulation by estrogen of HLA class I expression in breast tumor cell lines. Immunogenetics, 39, 161-167 (1994).
17. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Isolation of high-molecular-weight DNA from mammalian cells. In: C. Nolan (ed.), Molecular cloning, a laboratory manual, pp. 9.14-9.23, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989).
18. SCHULTZ HATER, E., JURETIC, A., DELLABONA, P., LUSCHER, U., SIEGRIST, W., HARDER, F., HEBERER, M., ZUBER, M. and SPAGNOLI, G.C., MAGE-1 gene product is a cytoplasmic protein. Int. J. Cancer, 59, 435-439 (1994).
19. SERRANO, A., GARCÍA, A., ABRIL, E., GARRIDO, F. and RUIZ-CAHELLO, F., Differential MAGE-1 gene expression in two variants of an erythroleukemic cell line (K562). Immunobiology, 194, 449-456 (1995).
20. TAKAHASHI, K., SCHICHIJO, S., NOGUCHI, M., HIROHATA, M. and ITOH, K., Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res., 55, 3478-3482 (1995).
21. TRAVERSARI, C., VAN DER BRUGGEN, P., VAN DEN EYNDE, B., HAINAUT, P., LEMOINE, C., OHTA, N., OLD, L. and BOON, T., Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics, 35, 145-152 (1992).
22. VAN DER BRUGGEN, P., TRAVERSARI, C., CHOMEZ, P., LUROUIN, C., DE PLAEN, E., VAN DEN EYNDE, B., KNUTH, A. and BOON, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash.), 254, 1643-1647 (1991).
23. WEBER, J., SALGALLER, M., SAMID, D., JOHNSON, B., HERLYN, M., LASSAM, N., TREISMAN, J. and ROSENBERG, S.A., Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2′-deoxycytidine. Cancer Res., 54, 1766-1771 (1994).
24. WEYNANTS, P., LETHE, B., BRASSEUR, F., MARCHAND, M. and BOON, T., Expression of MAGE genes by non-small-cell lung carcinomas. Int. J. Cancer, 56, 826-829 (1994).
25. WILSON, V.L. and JONES, P.A., DNA methylation decreases in aging but not in immortal cells. Science (Wash.), 220, 1055-1057 (1983).